AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
LEVONOGESTREL
6 registrations across 3 African markets— 3 active
Markets with LEVONOGESTREL
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Revoke -72 tablets Tablet Uncoated | 🇿🇲Zambia | Senador Laboratories Private Limited | active | Aug 2030 |
| Microlut tablets Sugar Coated Tablets | 🇿🇲Zambia | Bayer (Pty) Ltd | active | Jul 2030 |
| Lenor 72 Tablets Film-coated Tablets | 🇿🇲Zambia | Unicure Remedies Pvt Ltd | active | May 2029 |
| MERINA 52MG INTRAUTERINE DEVICE INTRAUTERINE DEVICE | 🇲🇼Malawi | — | expired | Mar 2025 |
| POSTPILL 1.5MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| POSTIGA 4 TABLETS | 🇳🇬Nigeria | ONIFAM LABORATORIES LIMITED 113 | expired | Feb 2023 |
LEVONOGESTREL in Africa — Regulatory Overview
LEVONOGESTREL is registered across 3 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Zambia, Malawi, Nigeria. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 3 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.